Combined effects of moderately elevated blood glucose and locally produced TGF-β1 on glomerular morphology and renal collagen production

Nephrology Dialysis Transplantation

Volumn 22, Issue 9, 2007, Pages 2485-2496

  Krag, Søren ^a   Nyengaard, Jens R ^a   Wogensen, Lise ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Diabetes; Fibrosis; Kidney disease; Non diabetic glomerulopathy; Post transplant diabetes; TGF 1

Indexed keywords

COLLAGEN; GELATINASE A; GELATINASE B; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEINASE; STREPTOZOCIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE COURSE; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; GLOMERULAR STRUCTURE; GLUCOSE BLOOD LEVEL; GRAFT RECIPIENT; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY GRAFT; MALE; MESANGIUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; COLLAGEN; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; GLOMERULAR BASEMENT MEMBRANE; GLOMERULAR MESANGIUM; IMMUNOHISTOCHEMISTRY; KIDNEY GLOMERULUS; MALE; MICE; MICE, INBRED C57BL; PEPTIDE HYDROLASES; PHOSPHOPROTEINS; PROTEASE INHIBITORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 34548437070     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm229     Document Type: Article

References (32)

1. Miles AM, Sumrani N, Horowitz R et al. Diabetes mellitus after renal transplantation: As deleterious as non-transplant-associated diabetes? Transplantation 1998; 65: 380-384
2. Schiel R, Heinrich S, Steiner T, Ott U, Stein G. Long-term prognosis of patients after kidney transplantation: A comparison of those with or without diabetes mellitus. Nephrol, Dial Transplant 2005; 20: 611-617
3. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178-185
4. Gerhardt U, Grosse HM, Hohage H. Influence of hyperglycemia and hyperuricemia on long-term transplant survival in kidney transplant recipients. Clin Transplant 1999; 13: 375-379
5. Revanur VK, Jardine AG, Kingsmore DB et al. Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation. Clin Transplant 2001; 15: 89-94
6. Vanhille P. The diabetic patient with renal insufficiency. Diabetes Metab 2000; 26: 67-72
7. Altman JJ, Elian N, Grun S, Gerard HG, Feldman S. The outcome of advanced chronic nephropathy in type 1 and type 2 diabetic and non-diabetic patients: A prospective study. Diabetes Metab 1999; 25: 144-149
8. Flyvbjerg A. Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease. Diabetologia 2000; 43: 1205-1223
9. Cheng J, Grande JP. Transforming growth factor-beta signal transduction and progressive renal disease. Exp Biol Med (Maywood) 2002; 227: 943-956
10. Shihab FS, Andoh TF, Tanner AM et al. Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy. Kidney Int 1996; 49: 1141-1151
11. Eddy AA. Molecular basis of renal fibrosis. Pediatr Nephrol 2000; 15: 290-301
12. Wogensen L, Nielsen CB, Hjorth P et al. Under control of the Ren-1c promoter, locally produced transforming growth factor-beta1 induces accumulation of glomerular extracellular matrix in transgenic mice. Diabetes 1999; 48: 182-192
13. Nyengaard JR. Stereologic methods and their application in kidney research. J Am Soc Nephrol 1999; 10: 1100-1123
14. Gundersen HJG, Jensen TB, Osterby R. Distribution of membrane thickness determined by lineal analysis. J Microsc 1978; 113: 27-43
15. Gilbert RE, Wilkinson-Berka JL, Johnson DW et al. Renal expression of transforming growth factor-beta inducible gene-h3 (beta ig-h3) in normal and diabetic rats. Kidney Int 1998; 54: 1052-1062
16. Toyoda M, Suzuki D, Houma M et al. High expression of PKC-MAPK pathway mRNAs correlates with glomerular lesions in human diabetic nephropathy. Kidney Int 2004; 66: 1107-1114
17. Fujita H, Omori S, Ishikura K, Hida M, Awazu M. ERK and p38 mediate high-glucose-induced hypertrophy and TGF-beta expression in renal tubular cells. Am J Physiol Renal Physiol 2004; 286: F120-F126
18. Osterby R, Brekke IB, Gundersen HJ et al. Quantitative studies of glomerular ultrastructure in human and experimental diabetes. Appl Pathol 1984; 2: 205-211
19. Sharma K, Jin YL, Guo J, Ziyadeh FN. Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 1996; 45: 522-530
20. Flyvbjerg A, Dagnaes-Hansen F, De Vriese AS et al. Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes 2002; 51: 3090-3094
21. McLennan SV, Kelly DJ, Cox AJ et al. Decreased matrix degradation in diabetic nephropathy: Effects of ACE inhibition on the expression and activities of matrix metalloproteinases. Diabetologia 2002; 45: 268-275
22. McLennan SV, Wang XY, Moreno V, Yue DK, Twigg SM. Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: implications for diabetic nephropathy. Endocrinology 2004; 145: 5646-5655
23. Cheng S, Pollock AS, Mahimkar R, Olson JL, Lovett DH. Matrix metalloproteinase 2 and basement membrane integrity: A unifying mechanism for progressive renal injury. FASEB J 2006; 20: 1898-1900
24. Hayashida T, Schnaper HW. High ambient glucose enhances sensitivity to TGF-beta1 via extracellular signal-regulated kinase and protein kinase C delta activities in human mesangial cells. J Am Soc Nephrol 2004; 15: 2032-2041
25. Hayashida T, Poncelet AC, Hubchak SC, Schnaper HW. TGF-beta1 activates MAP kinase in human mesangial cells: A possible role in collagen expression. Kidney Int 1999; 56: 1710-1720
26. Fraser D, Wakefield L, Phillips A. Independent regulation of transforming growth factor-beta1 transcription and translation by glucose and platelet-derived growth factor. Am J Pathol 2002; 161: 1039-1049
27. Riser BL, Cortes P, Yee J et al. Mechanical strain- and high glucose-induced alterations in mesangial cell coltagen metabolism: Role of TGF-beta. J Am Soc Nephrol 1998; 9: 827-836
28. Ha SW, Bae JS, Yeo HJ et al. TGF-beta-induced protein beta ig-h3 is upregulated by high glucose in vascular smooth muscle cells. J Cell Biochem 2003; 88: 774-782
29. Hyytiainen M, Penttinen C, Keski-Oja J. Latent TGF-beta binding proteins: Extracellular matrix association and roles in TGF-beta activation. Crit Rev Clin Lab Sci 2004; 41: 233-264
30. Tojo A, Onozato ML, Ha H et al. Reduced albumin reabsorption in the proximal tubule of early-stage diabetic rats. Histochem Cell Biol 2001; 116: 269-276
31. Palm F, Ortsater H, Hansell P, Liss P, Carlsson PO. Differentiating between effects of streptozotocin per se and subsequent hyperglycemia on renal function and metabolism in the streptozotocin-diabetic rat model. Diabetes Metab Res Rev 2004; 20: 452-459
32. Wong TY, Choi PC, Szeto CC et al. Renal outcome in type 2 diabetic patients with or without coexisting non-diabetic nephropathies. Diabetes Care 2002; 25: 900-905.